Director - Analytical Chemistry

At Lilly, we unite caring with discovery to make life better for people around the world. Verve Therapeutics, a wholly owned subsidiary, focuses on developing gene editing medicines to protect against heart disease. The company aims to create transformative, once-and-done therapies using gene editing to permanently lower LDL cholesterol and triglyceride levels.

This role serves as a leader within Verve's Analytical Development function. You will recruit, shape, and lead a team of scientists and associates building analytical capabilities for the late-stage pipeline. The position architects next-generation analytical methods for extended characterization of RNA drug substances and LNP drug products.

You will operate at the intersection of science and strategy, partnering with cross-functional teams across Lilly's Product Research & Development organization. Your team supports non-GMP testing for comparability assessments, process development, stability, and product characterization studies. As part of the Technical Operations team, you influence how the function is built.

This is a rare opportunity to build analytical capabilities from the ground up. You will drive programs from development through commercialization while providing technical expertise for structural characterization of gRNAs, mRNAs, and lipid nanoparticle complexes. The role offers real influence over function direction and meaningful impact on human health.